Question

一段医学英文翻译成中文，非常感谢！

This was a 30-day, multicenter,double-blind, placebo-controlled, randomized, parallel-design trial conductedat 2 academic, out-patient pain clinics in the United States in patients with post-herpetic neuralgia (PHN) located on the torso or limbs. Patients underwent 2 treatment sessions in the clinic that were at least 48 hours apart where testpatches were applied to PHN-skin for a period of 10 hours. The patients went onto complete a home-use study phase of 21-28 days duration during which they were permitted to use up to 3 patches per day for a maximum of 12 hours in a 24-hour period. Upon completion of this home-use phase, the patients returnedto the clinic for their final study visit where they were given the option of participatingin an open-label trial with the Lidoderm™ Patch to assess long-term safety associated with continuous patch use.

Answer 1

ybenben12,你好， 偶是阿虚

该段临床实验论文摘要偶已译好。

This was a 30-day, multicenter,double-blind, placebo-controlled, randomized, parallel-design trial conductedat 2 academic, out-patient pain clinics in the United States in patients with post-herpetic neuralgia (PHN) located on the torso or limbs. Patients underwent 2 treatment sessions in the clinic that were at least 48 hours apart where testpatches were applied to PHN-skin for a period of 10 hours.

此试验采用平行设计，历经30日，为安慰剂对照的多中心，双盲随机试验，于美国两学术下属疼痛门诊进行。试验主要针对位于躯干和四肢的疱疹后神经痛（PHN)病人，病人共经两个相距至少48小时的疗程，其中测试贴剂贴于PHN患处10小时。

The patients went onto complete a home-use study phase of 21-28 days duration during which they were permitted to use up to 3 patches per day for a maximum of 12 hours in a 24-hour period. Upon completion of this home-use phase, the patients returned to the clinic for their final study visit where they were given the option of participatingin an open-label trial with the Lidoderm™ Patch to assess long-term safety associated with continuous patch use.

病人在21-28日阶段进行完全家中使用测试，此阶段他们被允许最多一日使用三贴，并在24小时内不超过12小时贴敷。在家中使用阶段后，病人进行最后一次复诊，并可选择参与Lidoderm贴剂非盲试验，以助评估长期，持续使用该贴剂的安全性。

Sincerely,

Kyon